Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias G Wacker

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Environmental Research|September 27, 2020
Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug productsFabian Jung, Manuela Thurn, Katharina Krollik, et al.
Molecules (Basel, Switzerland)|February 10, 2021
Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with DoxorubicinTatyana Kovshova, Nadezhda Osipova, Anna Alekseeva, et al.
Frontiers in Pharmacology|July 14, 2022
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical ImplicationsAmir Hossein Miri, Mojtaba Kamankesh, Antoni Llopis-Lorente, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2018
Stimulating brain recovery after stroke using theranostic albumin nanocarriers loaded with nerve growth factor in combination therapyTivadar Feczkó, Albrecht Piiper, Saema Ansar, et al.
International Journal of Pharmaceutics|July 1, 2015
Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufactureMônica Villa Nova, Christine Janas, Mike Schmidt, et al.
Nanoscale|August 29, 2020
Micro cell vesicle technology (mCVT): a novel hybrid system of gene delivery for hard-to-transfect (HTT) cellsYi-Hsuan Ou, Shui Zou, Wei Jiang Goh, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|April 2, 2021
Microparticle formulations alter the toxicity of fenofibrate to the zebrafish Danio rerio embryoIndra Hering, Elke Eilebrecht, Michael J Parnham, et al.
ACS Nano|February 15, 2024
A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin NanosimilarsShakti Nagpal, Jordan Png Yi Jie, Julia Malinovskaya, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 11, 2023
Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori InfectionMojtaba Kamankesh, Abbas Yadegar, Antoni Llopis-Lorente, et al.
International Journal of Pharmaceutics|September 5, 2021
Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical dataHarshvardhan Modh, Daniel Juncheng Fang, Yi Hsuan Ou, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Environmental Research|September 27, 2020
Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug productsFabian Jung, Manuela Thurn, Katharina Krollik, et al.
Molecules (Basel, Switzerland)|February 10, 2021
Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with DoxorubicinTatyana Kovshova, Nadezhda Osipova, Anna Alekseeva, et al.
Frontiers in Pharmacology|July 14, 2022
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical ImplicationsAmir Hossein Miri, Mojtaba Kamankesh, Antoni Llopis-Lorente, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2018
Stimulating brain recovery after stroke using theranostic albumin nanocarriers loaded with nerve growth factor in combination therapyTivadar Feczkó, Albrecht Piiper, Saema Ansar, et al.
International Journal of Pharmaceutics|July 1, 2015
Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufactureMônica Villa Nova, Christine Janas, Mike Schmidt, et al.
Nanoscale|August 29, 2020
Micro cell vesicle technology (mCVT): a novel hybrid system of gene delivery for hard-to-transfect (HTT) cellsYi-Hsuan Ou, Shui Zou, Wei Jiang Goh, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|April 2, 2021
Microparticle formulations alter the toxicity of fenofibrate to the zebrafish Danio rerio embryoIndra Hering, Elke Eilebrecht, Michael J Parnham, et al.
ACS Nano|February 15, 2024
A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin NanosimilarsShakti Nagpal, Jordan Png Yi Jie, Julia Malinovskaya, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 11, 2023
Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori InfectionMojtaba Kamankesh, Abbas Yadegar, Antoni Llopis-Lorente, et al.
International Journal of Pharmaceutics|September 5, 2021
Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical dataHarshvardhan Modh, Daniel Juncheng Fang, Yi Hsuan Ou, et al.
Pageof 7